NIM
VYGR icon

NEOS Investment Management’s Voyager Therapeutics VYGR Stock Holding History

NEOS Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,960
Closed -$46.5K – 651
2025
Q2 		$46.5K Hold
14,960
– – ﹤0.01% 616
2025
Q1 		$50.6K Hold
14,960
– – ﹤0.01% 597
2024
Q4 		$84.8K Hold
14,960
– – ﹤0.01% 586
2024
Q3 		$87.5K Hold
14,960
– – ﹤0.01% 577
2024
Q2 		$118K Hold
14,960
– – ﹤0.01% 566
2024
Q1 		$139K Buy
+14,960
New +$126K 0.01% 560

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

NEOS Investment Management's VYGR Position: Q3 2025 in Review

NEOS Investment Management sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 14,960 shares — an estimated $46.5K sold.

NEOS Investment Management first reported a position in VYGR in Q1 2024 and held it in 6 quarters. The position peaked at $139K in Q1 2024. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • NEOS Investment Management reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • NEOS Investment Management sold 14,960 Voyager Therapeutics shares in Q3 2025, an estimated $46.5K.
  • NEOS Investment Management first reported a position in Voyager Therapeutics in Q1 2024 and held it in 6 quarters.
  • NEOS Investment Management's Voyager Therapeutics position peaked at $139K in Q1 2024.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on NEOS Investment Management's 13F filing for Q3 2025, filed 7 Nov 2025.